Literature DB >> 8786430

Extracellular human immunodeficiency virus type 1 Tat protein promotes aggregation and adhesion of cerebellar neurons.

M J Orsini1, C M Debouck, C L Webb, P G Lysko.   

Abstract

Recombinant human immunodeficiency virus (HIV-1) Tat protein added to the culture medium of rat cerebellar neurons promoted aggregation and formation of spoke-like neurites in a dose-dependent manner. Tat proteins containing mutations in the Arg-Gly-Asp (RGD) cell adhesion motif or a deletion of the cysteine-rich domain had no effect on neuronal morphology. In contrast, a Tat protein that contained a deletion of the proline-rich domain promoted neuronal aggregation. Aggregation of neurons was inhibited by the addition of monoclonal antibodies directed against the RGD and basic domains of Tat, but not against the proline-rich domain. The same domains of Tat required to induce aggregation also mediated adhesion of neurons to Tat-coated substrates. The HIV-2 Tat protein, which lacks an RGD sequence but contains cysteine-rich and basic domains similar to HIV-1 Tat, induced aggregation and acted as a substrate for adhesion when added at higher concentrations than HIV-1 Tat. Vitronectin, fibronectin, and RGD-containing peptides did not induce morphological changes in neurons or act as substrates for adhesion. The ability of Tat to induce morphological changes and promote adhesion was independent of the ability of Tat to transactivate HIV gene expression. Our results suggest that extracellular Tat protein most likely alters neuronal morphology and mediates adhesion by acting in a manner similar to an extracellular matrix protein.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8786430      PMCID: PMC6578759     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  12 in total

1.  Identification of specific molecular structures of human immunodeficiency virus type 1 Tat relevant for its biological effects on vascular endothelial cells.

Authors:  S Mitola; R Soldi; I Zanon; L Barra; M I Gutierrez; B Berkhout; M Giacca; F Bussolino
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

2.  Molecular determinants for cellular uptake of Tat protein of human immunodeficiency virus type 1 in brain cells.

Authors:  M Ma; A Nath
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Cannabinoids inhibit migration of microglial-like cells to the HIV protein Tat.

Authors:  Daniel Fraga; Erinn S Raborn; Gabriela A Ferreira; Guy A Cabral
Journal:  J Neuroimmune Pharmacol       Date:  2011-07-07       Impact factor: 4.147

4.  Tat expression led to increased histone 3 tri-methylation at lysine 27 and contributed to HIV latency in astrocytes through regulation of MeCP2 and Ezh2 expression.

Authors:  Ying Liu; Yinghua Niu; Lu Li; Khalid A Timani; Victor L He; Chris Sanburns; Jiafeng Xie; Johnny J He
Journal:  J Neurovirol       Date:  2019-04-24       Impact factor: 2.643

5.  Exosome-associated release, uptake, and neurotoxicity of HIV-1 Tat protein.

Authors:  Pejman Rahimian; Johnny J He
Journal:  J Neurovirol       Date:  2016-05-12       Impact factor: 2.643

6.  Human immunodeficiency virus-1 Tat activates calpain proteases via the ryanodine receptor to enhance surface dopamine transporter levels and increase transporter-specific uptake and Vmax.

Authors:  Seth W Perry; Justin Barbieri; Ning Tong; Oksana Polesskaya; Santosh Pudasaini; Angela Stout; Rebecca Lu; Michelle Kiebala; Sanjay B Maggirwar; Harris A Gelbard
Journal:  J Neurosci       Date:  2010-10-20       Impact factor: 6.167

Review 7.  Cortical consequences of HIV-1 Tat exposure in rats are enhanced by chronic cocaine.

Authors:  Wesley N Wayman; Lihua Chen; Amanda L Persons; T Celeste Napier
Journal:  Curr HIV Res       Date:  2015       Impact factor: 1.581

8.  Interaction of the protein transduction domain of HIV-1 TAT with heparan sulfate: binding mechanism and thermodynamic parameters.

Authors:  André Ziegler; Joachim Seelig
Journal:  Biophys J       Date:  2004-01       Impact factor: 4.033

9.  Loss of cerebellar neurons in the progression of lentiviral disease: effects of CNS-permeant antiretroviral therapy.

Authors:  Christian Wächter; Lee E Eiden; Nedye Naumann; Candan Depboylu; Eberhard Weihe
Journal:  J Neuroinflammation       Date:  2016-10-14       Impact factor: 8.322

10.  Molecular characterization of full-length Tat in HIV-1 subtypes B and C.

Authors:  Chandra Nath Roy; Irona Khandaker; Yuki Furuse; Hitoshi Oshitani
Journal:  Bioinformation       Date:  2015-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.